ClearView cCAD

General Surgery Oncology Radiology

Regulatory Status Disclosed

Overview

ClearView cCAD is a software application designed to assist skilled physicians in analyzing breast ultrasound images. It automatically classifies shape and orientation characteristics of user-selected regions of interest (ROIs) using multivariate pattern recognition methods. The software enables users to annotate, tag, measure, and automatically record and/or store selected views. It also generates reports from user inputs annotated during the image analysis process, as well as from automatically generated characteristics.

Based on core BI-RADS models and lesion characteristic extraction algorithms, ClearView cCAD is a platform-agnostic web service that queries and accepts DICOM compliant digital medical files from ultrasound devices, other DICOM sources, or PACS servers. The tool leverages deep learning techniques to help radiologists analyze large amounts of data, primarily focused on breast cancer diagnosis, with the potential to extend to other cancers and diseases. Notably, ClearView Diagnostics Inc. was rebranded as Koios Medical, and the software is now known as Koios™ DS.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Assists physicians in analyzing breast ultrasound images
  • Automatically classifies shape and orientation characteristics of user-selected regions of interest (ROIs)
  • Utilizes multivariate pattern recognition methods
  • Allows user annotation, tagging, measurement, and storage of views
  • Automatically generates reports from user inputs
  • Based on core BI-RADS models and lesion characteristic extraction algorithms
  • Queries and accepts DICOM compliant digital medical files from various sources (ultrasound, PACS)
  • Aims to reduce unnecessary biopsies by identifying benign conditions
  • Employs deep learning and artificial intelligence techniques
  • Platform-agnostic web service

Use Cases

  • Breast cancer diagnosis from ultrasound images
  • Reducing the number of unnecessary breast biopsies
  • Assisting radiologists in the interpretation of diagnostic images
  • Facilitating compliance with ACR BI-RADSu00ae assessment
  • Potential future application in lung, liver, prostate, and cardiovascular disease diagnosis

What Physicians Need to Know

Key Capabilities
ClearView cCAD is designed to aid in cardiac imaging analysis. It offers capabilities such as zoom, gate measurement, and spectral and tissue Doppler functions. The system aims to reduce inter-operator variance in cardiac imaging.
Compliance Status
ClearView Diagnostics Inc. has FDA filings for ClearView cCAD.
Pricing Model
The pricing model for ClearView cCAD is not publicly available. Other ClearView products often offer custom enterprise pricing with dedicated support and flexible contract terms.
Implementation Complexity
The implementation complexity for ClearView cCAD is not specified. For other ClearView platforms, implementation can range from a few days for small teams to 1-2 months for enterprise deployments with custom integrations.
Evidence Base
The evidence base for ClearView cCAD primarily consists of studies evaluating its ability to increase overall performance and reduce inter-operator variance in cardiac imaging.
Physician Tip

When considering ClearView cCAD, physicians should inquire about specific integration capabilities with existing PACS or EHR systems to ensure a seamless workflow. Understanding the detailed evidence base, particularly regarding its impact on diagnostic accuracy and efficiency in cardiac imaging, is crucial. Physicians should also seek information on training and support to maximize the utility of the tool in their practice.

While specific integrations for ClearView cCAD are not detailed, ClearView platforms generally offer robust integration ecosystems. It is advisable to confirm direct compatibility with your current imaging and health information systems, and to explore the availability of APIs for custom integrations.

Details

Category Oncology AI, Radiology & Imaging AI
Pricing Unknown
Compliance
BAA AvailableUnknown
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
Integrations
EHR Not specified
Specialties General Surgery, Oncology, Radiology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2016-12-28K161959 510(k)ClearView cCAD

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate ClearView cCAD

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for ClearView cCAD.

Loading videos...

View all on YouTube

Frequently Asked Questions

ClearView cCAD is designed to assist in oncology by providing consistent assessments, particularly in areas like ultrasonography classification. AI tools in oncology generally aim to improve diagnostic precision, support individualized treatment planning, and enhance patient management by integrating multimodal data such as imaging, pathology, genomics, and clinical records.
While specific regulatory details for ClearView cCAD from ClearView Diagnostics Inc. are not extensively detailed, AI tools in healthcare, especially for diagnostics, are subject to regulatory guidelines. Generally, AI systems in oncology should be FDA-cleared or CE-marked where applicable, and compliance with data privacy laws is crucial.
Several AI tools are available in oncology, each with different focuses. Some prominent examples include IBM Watson for Oncology for treatment recommendations, Tempus for genomic analysis and real-time data, PathAI for digital pathology, and Flatiron Health for real-world evidence. Other platforms like EvidenceMD focus on providing a reasoning layer over guidelines.
General limitations of AI in oncology include concerns about data quality, interpretability of algorithms, potential for bias in datasets, and the challenge of seamless integration into existing clinical workflows. Clinician mistrust due to a lack of understanding of AI mechanisms and the risk of over-reliance on technology are also significant limitations.
Specific details regarding ClearView cCAD's data privacy and security from ClearView Diagnostics Inc. are not available. However, in general, AI companies handling sensitive health data are expected to maintain robust security measures, including data encryption at rest and in transit, and compliance with relevant data privacy laws like HIPAA.

Related Tools

VERITON CT 400 Series Digital SPECT/CT System (VERITON CT 416/464)
Spectrum Dynamics Medical
Oncology AI
The VERITON CT 400 Series is a digital SPECT/CT system with a 360-degree gantry and 12 swiveling CZT detectors, offering high sensitivity and quantitative accuracy for a wide range of nuclear medicine applications, including advanced theranostics imaging.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
BIOGRAPH One
Siemens Healthineers AG
Oncology AI
BIOGRAPH One is a second-generation PET/MR scanner designed to transform PET/MR image quality for a new era, combining high PET precision with powerful MR performance. It enables simultaneous visualization of organ location, function, and cellular metabolism, offering faster image acquisition times and more efficient workflows than previous generations of PET/MR scanners.
Claire™ OCT System
Perimeter Medical Imaging AI
Oncology AI
Perimeter Medical Imaging AI is a medical technology company driven to transform cancer surgery with ultra-high resolution, real-time, advanced imaging tools that address unmet medical needs.S. for intraoperative breast cancer margin assessment.
syngo.via RT Image Suite VC10
Varian Medical Systems, Inc.
Clinical Decision Support & Reference
syngo.via RT Image Suite VC10 offers advanced imaging and workflow solutions for precise and efficient radiation therapy planning.

See all Oncology AI tools →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-05 | First Added: 2026-04-18
AI Tool Finder
AI-powered search. Results may not be comprehensive.